Gaines Kristin Sallee 4
4 · NATIONAL HEALTH INVESTORS INC · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Gaines Kristin Sallee
SVP/Chief Transaction Officer
Transactions
- Award
Common Stock
2024-02-23+3,000→ 51,609 total - Award
Stock Option (Right to Buy) 2024
2024-02-23+8,333→ 8,333 totalExercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - Award
Stock Option (Right to Buy) 2024
2024-02-23+8,333→ 8,333 totalExercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - Award
Stock Option (Right to Buy) 2024
2024-02-23+8,334→ 8,334 totalExercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,334 underlying)
Holdings
- 18,334
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (18,334 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2020-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2021-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2022-02-21Exp: 2025-02-21→ Common Stock (18,334 underlying) - 18,333
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - 18,333
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (18,334 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,334 underlying)
Footnotes (1)
- [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting February 23, 2025.